Bukowski RM - Search Results

1

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Among authors: bukowski rm. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

2

Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports.

Shaheen PE, Rini BI, Bukowski RM. Shaheen PE, et al. Among authors: bukowski rm. Clin Genitourin Cancer. 2006 Jun;5(1):78-81. doi: 10.3816/CGC.2006.n.021. Clin Genitourin Cancer. 2006. PMID: 16859583

3

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.

Suppiah R, Shaheen PE, Elson P, Misbah SA, Wood L, Motzer RJ, Negrier S, Andresen SW, Bukowski RM. Suppiah R, et al. Among authors: bukowski rm. Cancer. 2006 Oct 15;107(8):1793-800. doi: 10.1002/cncr.22237. Cancer. 2006. PMID: 16983701 Free article.

4

The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.

Choueiri TK, Bukowski RM, Rini BI. Choueiri TK, et al. Among authors: bukowski rm. Semin Oncol. 2006 Oct;33(5):596-606. doi: 10.1053/j.seminoncol.2006.06.003. Semin Oncol. 2006. PMID: 17045089 Review.

5

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski RM. Rini BI, et al. Among authors: bukowski rm. J Natl Cancer Inst. 2007 Jan 3;99(1):81-3. doi: 10.1093/jnci/djk008. J Natl Cancer Inst. 2007. PMID: 17202116

6

Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity.

Segota E, Mekhail T, Olencki T, Hutson TE, Dreicer R, Wacker B, Osterwalder B, Elson P, Zhou M, Bukowski RM. Segota E, et al. Among authors: bukowski rm. Urol Oncol. 2007 Jan-Feb;25(1):46-52. doi: 10.1016/j.urolonc.2006.02.016. Urol Oncol. 2007. PMID: 17208138 Clinical Trial.

7

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI, Bukowski RM. Choueiri TK, et al. Among authors: bukowski rm. Cancer. 2007 Aug 1;110(3):543-50. doi: 10.1002/cncr.22827. Cancer. 2007. PMID: 17577222 Free article.

8

Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma.

George S, Hutson TE, Mekhail T, Wood L, Finke J, Elson P, Dreicer R, Bukowski RM. George S, et al. Among authors: bukowski rm. Cancer Chemother Pharmacol. 2008 Jul;62(2):347-54. doi: 10.1007/s00280-007-0594-5. Epub 2007 Oct 2. Cancer Chemother Pharmacol. 2008. PMID: 17909807 Clinical Trial.

9

Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.

Tamaskar I, Garcia JA, Elson P, Wood L, Mekhail T, Dreicer R, Rini BI, Bukowski RM. Tamaskar I, et al. Among authors: bukowski rm. J Urol. 2008 Jan;179(1):81-6; discussion 86. doi: 10.1016/j.juro.2007.08.127. Epub 2007 Nov 12. J Urol. 2008. PMID: 17997441

10

Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma.

Heng DY, Rini BI, Garcia J, Wood L, Bukowski RM. Heng DY, et al. Among authors: bukowski rm. Clin Genitourin Cancer. 2007 Dec;5(7):446-51. doi: 10.3816/CGC.2007.n.033. Clin Genitourin Cancer. 2007. PMID: 18272027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters